BACKGROUND: The Institute of Medicine (IOM) proposed that cancer survivors and their primary care providers (PCPs) should receive survivorship care plans to inform ongoing care. We aimed to determine PCPs' preferences for the content of survivorship care plans for colorectal cancer (CRC) survivors. METHODS: PCPs in 3 practice-based research networks completed a survey regarding 45 topics of CRC information based on the IOM's survivorship care plan framework. RESULTS: One hundred fifty-six PCPs completed the survey. For 35 topics (78%), at least half of respondents felt the topic was very important. Most PCPs reported receiving too little information about problems with chemotherapy (68%) or radiation (60%) and whether the oncologist intended to monitor for other cancers (71%). PCPs widely agreed that they do not have enough information about increased risk of second CRCs, other cancers, and other diseases (78%); long-term effects of chemotherapy (73%) and radiation (67%); and genetic counseling (83%). CONCLUSIONS: PCPs endorse the IOM's survivorship care plan framework as relevant and often report needing more information. Survivorship care plans may provide important information to PCPs by communicating patients' cancer histories and making recommendations regarding which aspects of care should be provided by the oncologist or the PCP.
BACKGROUND: The Institute of Medicine (IOM) proposed that cancer survivors and their primary care providers (PCPs) should receive survivorship care plans to inform ongoing care. We aimed to determine PCPs' preferences for the content of survivorship care plans for colorectal cancer (CRC) survivors. METHODS: PCPs in 3 practice-based research networks completed a survey regarding 45 topics of CRC information based on the IOM's survivorship care plan framework. RESULTS: One hundred fifty-six PCPs completed the survey. For 35 topics (78%), at least half of respondents felt the topic was very important. Most PCPs reported receiving too little information about problems with chemotherapy (68%) or radiation (60%) and whether the oncologist intended to monitor for other cancers (71%). PCPs widely agreed that they do not have enough information about increased risk of second CRCs, other cancers, and other diseases (78%); long-term effects of chemotherapy (73%) and radiation (67%); and genetic counseling (83%). CONCLUSIONS: PCPs endorse the IOM's survivorship care plan framework as relevant and often report needing more information. Survivorship care plans may provide important information to PCPs by communicating patients' cancer histories and making recommendations regarding which aspects of care should be provided by the oncologist or the PCP.
Authors: Philip J Kroth; Laurie McPherson; Robert Leverence; Wilson Pace; Elvan Daniels; Robert L Rhyne; Robert L Williams Journal: Ann Fam Med Date: 2009 May-Jun Impact factor: 5.166
Authors: Arnold L Potosky; Paul K J Han; Julia Rowland; Carrie N Klabunde; Tenbroeck Smith; Noreen Aziz; Craig Earle; John Z Ayanian; Patricia A Ganz; Michael Stefanek Journal: J Gen Intern Med Date: 2011-07-22 Impact factor: 5.128
Authors: Claire F Snyder; Craig C Earle; Robert J Herbert; Bridget A Neville; Amanda L Blackford; Kevin D Frick Journal: J Clin Oncol Date: 2008-03-01 Impact factor: 44.544
Authors: Laura P Forsythe; Carla Parry; Catherine M Alfano; Erin E Kent; Corinne R Leach; David A Haggstrom; Patricia A Ganz; Noreen Aziz; Julia H Rowland Journal: J Natl Cancer Inst Date: 2013-10-04 Impact factor: 13.506
Authors: Deborah K Mayer; Adrian Gerstel; Annmarie Lee Walton; Tammy Triglianos; Teresa E Sadiq; Nikki A Hawkins; Janine M Davies Journal: Oncol Nurs Forum Date: 2014-05 Impact factor: 2.172
Authors: SarahMaria Donohue; Mary E Sesto; David L Hahn; Kevin A Buhr; Elizabeth A Jacobs; James M Sosman; Molly J Andreason; Douglas A Wiegmann; Amye J Tevaarwerk Journal: J Oncol Pract Date: 2015-03-24 Impact factor: 3.840
Authors: Steven C Palmer; Carrie Tompkins Stricker; SarahLena L Panzer; Sarah A Arvey; K Scott Baker; Jackie Casillas; Patricia A Ganz; Mary S McCabe; Larissa Nekhlyudov; Linda Overholser; Ann H Partridge; Betsy Risendal; Donald L Rosenstein; Karen L Syrjala; Linda A Jacobs Journal: J Oncol Pract Date: 2015-03 Impact factor: 3.840
Authors: Nicole P M Ezendam; Kim A H Nicolaije; Roy F P M Kruitwagen; Johanna M A Pijnenborg; M Caroline Vos; Dorry Boll; Marjo van Bommel; Lonneke V van de Poll-Franse Journal: J Cancer Surviv Date: 2014-05-28 Impact factor: 4.442
Authors: Rebecca E Hill; Claire E Wakefield; Richard J Cohn; Joanna E Fardell; Mary-Ellen E Brierley; Emily Kothe; Paul B Jacobsen; Kate Hetherington; Rebecca Mercieca-Bebber Journal: Oncologist Date: 2019-10-25
Authors: Rebecca E Hill; Claire E Wakefield; Richard J Cohn; Joanna E Fardell; Mary-Ellen E Brierley; Emily Kothe; Paul B Jacobsen; Kate Hetherington; Rebecca Mercieca-Bebber Journal: Oncologist Date: 2019-10-25
Authors: Talya Salz; Mary S McCabe; Erin E Onstad; Shrujal S Baxi; Richard L Deming; Regina A Franco; Lyn A Glenn; Gregory R Harper; Alcee J Jumonville; Roxanne M Payne; Elissa A Peters; Andrew L Salner; John M Schallenkamp; Sheron R Williams; Kevin Yiee; Kevin C Oeffinger Journal: Cancer Date: 2013-12-10 Impact factor: 6.860
Authors: Amye J Tevaarwerk; Kari B Wisinski; Kevin A Buhr; Ucheanna O Njiaju; May Tun; Sarah Donohue; Navnit Sekhon; Thomas Yen; Douglas A Wiegmann; Mary E Sesto Journal: J Oncol Pract Date: 2014-02-11 Impact factor: 3.840